Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00914381 · ClinicalTrials.gov registry record · Phase 2
Behavioral Treatment for Cocaine Dependent Women
A Phase 2 study of Cocaine Dependence, sponsored by Yale University.
- Completed
- Registry status
- Phase 2
- Development phase
- 145
- Enrollment target
- 2
- Study locations
NCT00914381: Completed Phase 2 study of Cocaine Dependence, sponsored by Yale University.
NCT00914381 is a Phase 2 study of Cocaine Dependence that has completed, run by Yale University. The registered enrollment target is 145 participants, below the 295-participant average among 38 other Cocaine Dependence trials with a reported enrollment target (51% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00914381, a Phase 2 study of Cocaine Dependence, has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 145 participants
- Enrollment target
- 2
- Study locations
Study Summary
To compare the efficacy of Community Reinforcement Approach (CRA) and 12-Step Facilitation (TSF) counseling and of voucher based reward therapy (VBRT) and a yoked, non-contingent voucher control (VC) for the treatment of cocaine dependent pregnant women or women with young children.
Conditions Studied
Interventions
- BEHAVIORAL Behavioral therapy
Study Locations (2)
Connecticut
- The APT Foundation, Inc. MRU - New Haven
- Yale University School of Medicine - New Haven
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 145 participants |
| Start Date | 1994-12 |
| Est. Completion | 2002-03 |
| Phase | Phase 2 |
What the finished NCT00914381 record still lists
NCT00914381 is an interventional study that assigns participants to a tested intervention. The registered 145 participants enrollment target is mid-sized for trials with a published cap, below the 295-participant average among 38 other Cocaine Dependence trials with a reported enrollment target (51% lower).
The record links to 1 condition, with Cocaine Dependence appearing as the primary indexed condition, and to 1 intervention - of which Behavioral therapy is the first listed.
NCT00914381 reports a single indexed study location in Connecticut.
Frequently Asked Questions
What is clinical trial NCT00914381 about?
NCT00914381 is a clinical study titled "Behavioral Treatment for Cocaine Dependent Women". To compare the efficacy of Community Reinforcement Approach (CRA) and 12-Step Facilitation (TSF) counseling and of voucher based reward therapy (VBRT) and a yoked, non-contingent voucher control (VC) for the treatment of cocaine dependent pregnant women or women with young children.
What is the current status of trial NCT00914381?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 145 participants. The study started on 1994-12. Estimated completion is 2002-03.
What conditions does trial NCT00914381 study?
This clinical trial studies the following conditions: Cocaine Dependence.
What interventions are being tested in trial NCT00914381?
The interventions under investigation include: Behavioral therapy (BEHAVIORAL).
Who is sponsoring clinical trial NCT00914381?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00914381 being conducted?
This trial has 2 study locations across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cocaine Dependence
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00914381's enrollment target sits among peer trials
145 13th of 38 higher than 26 of 38 other Cocaine Dependence trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cocaine Dependence trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Clavulanic Acid for the Treatment of Cocaine Use Disorder
ACTIVE NOT RECRUITING · Phase 2
-
Glutamatergic Modulation of Cocaine-related Deficits
COMPLETED · Phase 2
-
Disulfiram for Cocaine Abuse
COMPLETED · Phase 2
-
Multicenter Trial of Combined Pharmacotherapy to Treat Cocaine Dependence
COMPLETED · Phase 2
-
Citalopram for Cocaine Dependence
COMPLETED · Phase 2
-
PHASE IIA: Trial of a Novel Ondansetron Formulation (OND-PR002) and Immediate-Release Methylphenidate (Ritalin®)(OND003IND)
COMPLETED · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02688959 · 145 participants · NA
Motor Attention Training for Attention Deficit Hyperactivity Disorder (ADHD)
- NCT03586609 · 145 participants · Phase 2
Venetoclax, Cladribine, Low Dose Cytarabine, and Azacitidine in Treating Patients With Previously Untreated Acute Myeloid Leukemia
- NCT03767595 · 145 participants · NA
ProACT Post-Approval Study
- NCT03808337 · 145 participants · Phase 2
Investigating the Effectiveness of Stereotactic Body Radiotherapy (SBRT) in Addition to Standard of Care Treatment for Cancer That Has Spread Beyond the Original Site of Disease
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia